KKR & Co. Inc. acquires Gamma Biosciences

On February 18, 2020, KKR & Co. Inc. acquired Gamma Biosciences, a life science company in California, United States.

Deal at a glance

AnnouncedFebruary 18, 2020 TypeConsolidation TargetGamma Biosciences Buyer KKR & Co. Inc. SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

Gamma Biosciences

California, United States

Life Sciencesector

2010founded

Activestatus

View the company profile →

Buyer

KKR & Co. Inc.

Private equity firm · 428 deals on record

11th transaction in life science
141st transaction in United States

428deals, all time

14in this sector

2026latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Gen II Fund Services LLCSame lead buyer · Oct 2026

Ci FLAVORS Co., Ltd.Same lead buyer · Aug 2026

Medicover IndiaSame lead buyer · Aug 2026

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Gamma Biosciences?KKR & Co. Inc. acquired Gamma Biosciences on February 18, 2020.

What type of deal was it?It was a consolidation in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).